Test Price
2,800 AED✅ Home Collection Available
CTDP1 Gene Sequencing for Charcot-Marie-Tooth Disease Type 4 | 2800 AED | 2026 DHA Guidelines
تحليل جين CTDP1 لمرض شاركو-ماري-توث في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Guarantee.
- 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited Next-Generation Sequencing (NGS) processing, guaranteeing precise variant detection.
- VIP Mobile Phlebotomy with hospital-grade, ISO-certified cold-chain home collection across the UAE (8 AM - 11 PM).
- Telephonic Post-Test Clinical Guidance provided by a DHA-licensed genetic specialist to aid in result interpretation.
- Insurance Direct Billing Verification instantly via WhatsApp at +971 54 548 8731.
ملخص تنفيذي: تقدم هذه الخدمة التشخيصية المتطورة تحليلًا جينيًا شاملاً لجين CTDP1 المرتبط بمرض شاركو-ماري-توث من النوع الرابع، وذلك وفق أعلى معايير هيئة الصحة بدبي لعام 2026. نضمن أعلى درجات الدقة والخصوصية الكاملة للبيانات، مع خدمة سحب عينات منزلية معتمدة ودعم تأميني مباشر لضمان راحة البال.
1. Overview: CTDP1 NGS Test for Charcot-Marie-Tooth Disease
This test utilizes Next-Generation Sequencing (NGS) to analyze the entire coding region of the CTDP1 gene, definitively diagnosing Charcot-Marie-Tooth disease type 4 (CMT4). طفرة جين CTDP1 تسبب اعتلال الأعصاب المحيطي الوراثي الشديد المعروف باسم مرض شاركو-ماري-توث.
| Feature | Our Test (CTDP1 NGS) | Closest Alternative (Single-Gene Sanger Sequencing) |
|---|---|---|
| Diagnostic Precision | Full gene coverage identifies 99.9% of pathogenic variants. | Limited to known hotspot mutations, missing novel variants. |
| Methodology | High-throughput NGS (Illumina NovaSeq X Plus platform). | Capillary electrophoresis Sanger method. |
| Turnaround Time | 3-4 Weeks | 6-8 Weeks |
2. Physician Insight & Safety Protocol
Clinical Note from Dr. PRABHAKAR REDDY (DHA License: 61713011): "As a consultant neurologist, I emphasize that a genetic diagnosis is a landmark, not a final verdict. This precise CTDP1 result illuminates a clear diagnostic path but must be correlated with your clinical history—nerve conduction studies and physical examination findings remain irreplaceable for holistic care planning. We are here to translate this complex code into a compassionate, actionable plan for your family."
⚠️ Critical Medication Warning
Do not discontinue or alter any prescribed neurological or supportive medication without explicit consultation with your supervising physician. Abrupt cessation can unmask severe symptoms.
Patient Safety Exclusion & ER Red Flags
- Exclusion Criteria: This test cannot be performed on a sample without complete patient identification or a requisition form signed by a referring physician. We cannot accept blood samples from patients who have received an allogeneic bone marrow transplant within the last 6 weeks.
- Emergency Red Flags: If you experience acute onset of respiratory distress, severe muscle weakness leading to falls, or complete loss of sensation in limbs, do not wait for test results. Proceed immediately to your nearest Emergency Department or call 998 for an ambulance.
3. Patient FAQ & Clinical Guidance
Q: What does the CTDP1 NGS test definitively diagnose in a neurological context?
A: This test identifies pathogenic variants in the CTDP1 gene to provide a definitive molecular diagnosis of Charcot-Marie-Tooth Disease Type 4, a severe autosomal recessive hereditary motor and sensory neuropathy with distal weakness.
س: كم المدة اللازمة لظهور نتائج فحص جين CTDP1، وهل هي دقيقة؟
ج: تستغرق النتائج من 3 إلى 4 أسابيع، حيث نستخدم تقنية تسلسل الجيل التالي فائقة الدقة مع تغطية تحليلية كاملة للجين لضمان اكتشاف الطفرات المسببة للمرض بدقة تتجاوز 99.9%.
Q: How is my biological sample and genetic data protected under UAE law?
A: We adhere strictly to Federal Decree-Law No. 41 of 2024 and UAE PDPL, ensuring your DNA sample and genetic report are pseudonymized, encrypted, and inaccessible to third parties including insurers without your explicit, revocable consent.
UAE Legal & Regulatory Compliance
- This service strictly operates under Federal Decree-Law No. 41 of 2024 (Article 87) for patient safety and clinical waste management.
- Full compliance with UAE CDS Law 2026 for genetic testing in minors, requiring legal guardian consent and genetic counselling.
- Data privacy is guaranteed by UAE Personal Data Protection Law (PDPL), with servers hosted locally within the UAE.
- Laboratory accreditation certified by ISO 9001:2015 (Certificate No: INT/EGQ/2509DA/3139).
- Pre- genetic counselling is mandatory. We facilitate a session to draw a pedigree chart of family members affected by CTDP1.
- Sample collection is performed by DHA/MOHAP licensed phlebotomists under facility license 9834453.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians